AU2003223186A1 - SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2 - Google Patents

SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2

Info

Publication number
AU2003223186A1
AU2003223186A1 AU2003223186A AU2003223186A AU2003223186A1 AU 2003223186 A1 AU2003223186 A1 AU 2003223186A1 AU 2003223186 A AU2003223186 A AU 2003223186A AU 2003223186 A AU2003223186 A AU 2003223186A AU 2003223186 A1 AU2003223186 A1 AU 2003223186A1
Authority
AU
Australia
Prior art keywords
coexpression
erbb
neu
assays
detect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003223186A
Inventor
Jan Zavada
Silvia Pastorekova
Jaromir Pastorek
Zuzanna Zavadova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Institute of Virology (Slovak Academy of Science)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Virology (Slovak Academy of Science) filed Critical Institute of Virology (Slovak Academy of Science)
Priority claimed from PCT/US2003/005137 external-priority patent/WO2004005348A1/en
Publication of AU2003223186A1 publication Critical patent/AU2003223186A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Husbandry (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2003223186A 2002-05-23 2003-02-21 SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2 Abandoned AU2003223186A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38306802P 2002-05-23 2002-05-23
US43149902P 2002-12-05 2002-12-05
PCT/US2003/005137 WO2004005348A1 (en) 2002-02-21 2003-02-22 SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2

Publications (1)

Publication Number Publication Date
AU2003223186A1 true AU2003223186A1 (en) 2004-01-23

Family

ID=29586977

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003223186A Abandoned AU2003223186A1 (en) 2002-05-23 2003-02-21 SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2

Country Status (2)

Country Link
AU (1) AU2003223186A1 (en)
WO (1) WO2003100029A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1743038A4 (en) 2004-05-04 2007-11-21 Bayer Healthcare Mn/ca ix/ ca9 and renal cancer prognosis
DOP2006000277A (en) * 2005-12-12 2007-08-31 Bayer Pharmaceuticals Corp ANTI MN ANTIBODIES AND METHODS FOR USE
US7820159B2 (en) 2006-10-31 2010-10-26 Instiute of Virology of the Slovak Academy of Sciences MN/CA IX and EGFR pathway inhibition
US8097423B2 (en) 2007-07-30 2012-01-17 Institute Of Virology MN/CA IX and breast cancer therapy
WO2009059281A1 (en) * 2007-11-02 2009-05-07 Health Research Inc. Compositions and methods for using ca9 protein to stimulate an immune response
WO2009056342A1 (en) * 2007-11-02 2009-05-07 Wilex Ag Binding epitopes for g250 antibody
WO2020226612A1 (en) * 2019-05-06 2020-11-12 Navi Bio-Therapeutics, Llc Anti-carbonic anhydrase ix antibody
AU2019472821A1 (en) 2019-11-05 2022-06-09 Mabpro A.S. Humanized anti-CA IX antibodies and methods of their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024913A2 (en) * 1998-10-23 2000-05-04 Bayer Corporation Mn gene and protein

Also Published As

Publication number Publication date
WO2003100029A2 (en) 2003-12-04
WO2003100029A3 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
AU2003237958A1 (en) Composition containing at least one silicone-polyamide structured oil and a gelling agent, and methods of the use thereof
CA2435276A1 (en) Syntactic deformable foam compositions and methods for making
EP1038576A3 (en) Carbon dioxide gas absorbent
CA2411918A1 (en) Cubic liquid crystalline compositions and methods for their preparation
AU4053199A (en) Optical component, orientation layer, and layerable polymerisable mixture
AU5396000A (en) Plate-like multi-metal cyanide compounds, methods for their use and their use inthe production of polyethererpolyols
AU2002353010A1 (en) Composition for use in sealing a porous subterranean formation, and methods of making and using
EP2258351A3 (en) Granules containing lansoprazole in large amount
AU2003274973A1 (en) Thermostable reverse transcriptases and uses thereof
AU2003223186A1 (en) SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2
AU9313198A (en) Gas generant compositions, methods of production of the same and devices made therefrom
AU2003287038A1 (en) METHOD OF PREPARING (3R, 3aS, 6aR) -3- HYDROXYHEXAHYDROFURO (2, 3-b) FURAN AND RELATED COMPOUNDS
SI1256590T1 (en) Method for synthesis of (2S,3aS,7aS)-1-(S)-alanyl-octahydro-1H-indole-2- carboxylic acid derivatives and use in the synthesis of perindopril
AU2657499A (en) Synthesis of quinobenzoxazine analogues with topoisomerase ii and quadruplex interactions for use as antineoplastic agents
AU2003251695A1 (en) Novel thiophene derivatives, preparation method thereof and pharmaceutical compositions containing same
WO2000061594A3 (en) Nucleoside derivatives with photo-unstable protective groups
TW200505619A (en) Constituents of solder
WO2005003677A3 (en) Method of making inactive ballistic exercise elements and inactive ballistic element made by said method
AU6800400A (en) Method for anchoring oligonucleotides to a substrate
WO2001009373A3 (en) NATIVE Cdc25 SUBSTRATES, COMPOSITIONS AND USES RELATED THERETO
WO2004091489A3 (en) Topical blood pressure composition
AU2001272486A1 (en) Method for producing sol-gel compositions with a reduced solvent content and improved storage properties, and the use thereof
AU2002241277A1 (en) Functional plant, promoter to be used for producing the functional plant and method of using the same
AU2002322265A1 (en) Crystals and structure of 2c-methyl-d-erythritol 2,4-cyclodiphosphate synthase mecps
AU2003257608A1 (en) Inorganic compound containing active oxygen and process for producing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase